Does addition of a diagnostic contrast-enhanced CT to a contemporaneous PET/CT provide incremental value in patients for restaging of colorectal carcinoma?
Abstract Background Both constrast-enhanced computed tomography (ceCT) and 18F-Fluorodeoxyglucose positron emission tomography (PET) are widely used for evaluation of colorectal cancer. Not infrequently patients undergo both tests, increasing cost and radiation burden. Whether this combination provi...
Main Authors: | Kenneth S. K. Yap, Ojas H. Mehta, Wing Fai Eddie Lau, Tim Akhurst, Satish Warrier, Alexander Heriot, Rodney J. Hicks |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-11-01
|
Series: | European Journal of Hybrid Imaging |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41824-018-0046-y |
Similar Items
-
Clinical usefulness of PET-CT in staging, evaluation of treatment response and restaging of thoracic lymphoma
by: Ahmed Elsammak
Published: (2017-12-01) -
Accuracy of 18F-FDG PET/CT in detection and restaging of recurrent ovarian cancer
by: Waleed M. Hetta, et al.
Published: (2017-12-01) -
Value of contrast CT in combination with PET/CT in mesothelioma staging: Optimal protocol for initial assessment
by: Mohamed Houseni, et al.
Published: (2017-03-01) -
PET/CT in restaging, prognosis, and recurrence in patients with malignant melanoma
by: Kholoud H. El-Shourbagy, et al.
Published: (2020-08-01) -
The Role of PET-CT in Gastric Cancer — A Narrative Review
by: Raluca-Ioana Dascălu, et al.
Published: (2020-09-01)